Compare Indonesia Energy Corporation Limited (INDO) vs Revvity Inc (RVTY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Indonesia Energy Corporation Limited vs Revvity Inc — how do they compare? Indonesia Energy Corporation Limited trades at $2.74 (market cap $43.24M), while Revvity Inc trades at $154.18 (market cap $16.98B). The key difference: Revvity Inc is far larger — about 392.7× Indonesia Energy Corporation Limited's market cap, and Revvity Inc pays a 0.18% dividend while Indonesia Energy Corporation Limited pays none. Which is the better fit depends on your goals — on Pluang, investors hold Indonesia Energy Corporation Limited for 24 Days and Revvity Inc for 12 Days on average.
| INDO | RVTY | |
|---|---|---|
Market Cap | $43.24M | $16.98B |
Volume | 116,953 | 1,456,900 |
Sector | Energy | Health |
52-Week High | $6.74 | $157.36 |
52-Week Low | $2.49 | $82.26 |
Typical Hold Time | 24 Days | 12 Days |
Enterprise Value | $38.18M | $19.30B |
Dividend Yield | — | 0.18% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
INDO trades at $2.81, up 1.44% on the day, but exhibits a bearish technical signal with negative profitability metrics including a net income margin of -152.72% and ROE of -19.77% for 2025. Recent news highlights operational progress with the K-29 oil well discovery and production commencement, though financial results remain deeply negative. The stock's price-to-sales ratio is elevated at 15.2, and cash flow from operations is negative at -$5.43M, offset by financing inflows.
The outlook is speculative, hinging on successful production scaling from new wells to reverse persistent losses. Investment opportunity lies in potential revenue growth from oil operations, but risks include high cash burn, negative margins, and execution challenges in a volatile energy market. Analyst consensus is unanimously bullish with 3 buy ratings, suggesting optimism on future turnaround.
RVTY trades at $152.16, down 0.94% on the day, but maintains a bullish technical trend with strong moving average signals and support near $149. The company has consistently beaten earnings estimates in recent quarters, with Q3 2026 results expected soon. Revenue remains stable around $2.9 billion, though net income margins have softened slightly. Recent news highlights product launches and strategic acquisitions, such as the Human Cell Design deal, to bolster its life sciences portfolio.
The outlook is supported by analyst optimism with a 51.72% buy rating and a consensus price target of $132.13, though the current price trades above this target. Key risks include premium valuation metrics, margin pressures, and exposure to macroeconomic headwinds. The stock's proximity to its 52-week high suggests momentum but warrants caution given rich multiples.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Indonesia Energy Corporation Limited
Indonesia Energy is an oil and gas exploration and production company. It focuses on identifying and developing energy resources in Indonesia, primarily through its Kruh and Citarum blocks.
Read more on INDO →About Revvity Inc
Revvity, Inc., formerly the Life Sciences and Diagnostics businesses of PerkinElmer, is a global provider of scientific and diagnostic solutions. The company focuses on the health and wellness of humanity through its expertise in life science research, detection, imaging, and informatics. Revvity supplies a broad portfolio of instruments, reagents, and services to pharmaceutical companies, academic research institutions, and clinical laboratories worldwide, enabling customers to make advancements in human health.
Read more on RVTY →
